NMS Labs Webinars and Presentations

Designer Drugs Testing Solutions for Employers

Presented February 1, 2012
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services

The Expanding Reach of the Designer Drug Movement in 2011: Analytical and Interpretive Challenges for Forensic Toxicology and Chemistry

A live webinar hosted on October 26
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services

View the recorded presentation

Developments in Toxicology Support for the DRE Community

Co-hosted by NMS Labs and Draeger Safety Diagnostics, Inc.
July 2011
 Presented by Dr. Barry K. Logan

Oral Fluid as a Chemical Test for the DRE Program: History, the Future, and Practical Considerations

Presented at the IACP-DRE Conference
July 2011
by Dr. Barry K. Logan

Identification of Markers of JWH-018 and JWH-073 Use
in Human Urine

by Sherri L. Kacinko, Allan Xu,
Matthew M. McMullin, Barry K. Logan

K2 and Beyond: A Synthetic Cannabinoid Primer

Presented at the AAFS Annual Conference
February 2011
by Dr. Barry K. Logan, Lindsay Reinhold, Dr. Sherri Kacinko

K2 and the Synthetic Cannabinoids: Pharmacology, Effects and Chemical Analysis webinar

Presented September 16, 2010
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services

Salvia - Effects, Legal Status and Analysis webinar

Presented March 18, 2010
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services

New Highs: Salvia and K2
Solutions for the DRE Program

Presented July 2010 at the IACP DRE Conference
to Drug Recognition Experts across the nation
by Dr. Barry K. Logan, PhD, DABFT
NMS Labs National Director of Forensic Services

Bisphenol-A and Other Suspected Estrogenic Endocrine Disruptors

View presentations from the dinner that NMS Labs hosted during the 2010 Endocrine Society's Annual Meeting